GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $36,000 | +63.6% | 815 | +63.0% | 0.02% | +84.6% |
Q1 2022 | $22,000 | 0.0% | 500 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $22,000 | +15.8% | 500 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $19,000 | -5.0% | 500 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $20,000 | +11.1% | 500 | 0.0% | 0.01% | +8.3% |
Q1 2021 | $18,000 | 0.0% | 500 | 0.0% | 0.01% | -7.7% |
Q4 2020 | $18,000 | -5.3% | 500 | 0.0% | 0.01% | -18.8% |
Q3 2020 | $19,000 | -5.0% | 500 | 0.0% | 0.02% | -5.9% |
Q2 2020 | $20,000 | +5.3% | 500 | 0.0% | 0.02% | 0.0% |
Q1 2020 | $19,000 | -17.4% | 500 | 0.0% | 0.02% | 0.0% |
Q4 2019 | $23,000 | +9.5% | 500 | 0.0% | 0.02% | +6.2% |
Q3 2019 | $21,000 | +162.5% | 500 | +150.0% | 0.02% | +166.7% |
Q2 2018 | $8,000 | 0.0% | 200 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $8,000 | +14.3% | 200 | 0.0% | 0.01% | +20.0% |
Q4 2017 | $7,000 | -36.4% | 200 | -24.8% | 0.01% | -28.6% |
Q3 2017 | $11,000 | 0.0% | 266 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $11,000 | 0.0% | 266 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $11,000 | +266.7% | 266 | +303.0% | 0.01% | +250.0% |
Q4 2016 | $3,000 | -93.3% | 66 | -93.6% | 0.00% | -92.6% |
Q3 2016 | $45,000 | -28.6% | 1,035 | -27.9% | 0.03% | -27.0% |
Q2 2016 | $63,000 | -21.2% | 1,435 | -27.9% | 0.04% | -11.9% |
Q1 2016 | $80,000 | 0.0% | 1,990 | 0.0% | 0.04% | 0.0% |
Q4 2015 | $80,000 | +3.9% | 1,990 | 0.0% | 0.04% | -2.3% |
Q3 2015 | $77,000 | -7.2% | 1,990 | 0.0% | 0.04% | +2.4% |
Q2 2015 | $83,000 | -9.8% | 1,990 | 0.0% | 0.04% | -8.7% |
Q1 2015 | $92,000 | +8.2% | 1,990 | 0.0% | 0.05% | +9.5% |
Q4 2014 | $85,000 | -6.6% | 1,990 | 0.0% | 0.04% | -6.7% |
Q3 2014 | $91,000 | -15.0% | 1,990 | 0.0% | 0.04% | -11.8% |
Q2 2014 | $107,000 | 0.0% | 1,990 | 0.0% | 0.05% | 0.0% |
Q1 2014 | $107,000 | 0.0% | 1,990 | 0.0% | 0.05% | +2.0% |
Q4 2013 | $107,000 | +18.9% | 1,990 | +11.2% | 0.05% | +13.6% |
Q3 2013 | $90,000 | +1.1% | 1,790 | 0.0% | 0.04% | 0.0% |
Q2 2013 | $89,000 | – | 1,790 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |